Correction to Novartis Earnings Article
January 24 2018 - 2:30AM
Dow Jones News
The Swiss pharmaceuticals company reported fourth-quarter pretax
profit of $1.98 billion compared with $936 million during the same
period a year ago. "Novartis 4Q Profit Rises, Buoyed by Sales of
New Drugs," at 0635 GMT, misstated the period in the second
paragraph. The pretax profit and sales figures were for the fourth
quarter of 2017, not the third quarter.
(END) Dow Jones Newswires
January 24, 2018 02:15 ET (07:15 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024